CAPR vs ZYME
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
CAPR
ZYME
Investment Advisor Scores
ZYME
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CAPR | ZYME | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 78.7402 | 20.8333 | ZYME |
| PEG Ratio | 0.3831 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -7.9% | -90.6% | CAPR |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.1/100 | 35.2/100 | CAPR |
| Profit Margin | 0.0% | 0.0% | Tie |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | CAPR |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CAPR
MarkdownPrice below a falling SMA50 (slope -12.5%), weak momentum, RSI 35
ZYME
MarkupPrice above SMA50, rising 50-day trend (4.4% over 20 days), RSI 61
Fundamentals Snapshot
| Metric | CAPR | ZYME |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -4.2 | 31.5 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | -0.9% |
| Gross Margin | -9.0% | -2.5% |
| Operating Margin | 0.0% | -9.2% |
| EPS | -2.45 | -2.02 |
| Dividend Yield | — | — |